2-Sulfonyliminodihydropyrimidines: A novel class of analgesic compounds

Archiv der Pharmazie

Volumn 341, Issue 11, 2008, Pages 690-695

  González Rosende, M Eugenia ^a   Olivar, Teresa ^a   Castillo, Encarna ^a   Sepúlveda Arques, José ^b  

^a UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Anti inflammatory activity; Antinociceptive activity; Dihydropyrimidines

Indexed keywords

2 SULFONYLIMINODIHYDROPYRIMIDINE; [2 [[(4 METHYLPHENYL)SULFONYL]IMINO]PYRIMIDIN 1(2H) YL] N PHENYLACETAMIDE; ACETYLSALICYLIC ACID; N (4 BROMOPHENYL) 2 [(2 [(METHYLSULFONYL)IMINO]PYRIMIDIN 1(2H) YL]ACETAMIDE; N (4 HYDROXYPHENYL) 2 [[[(4 METHYLPHENYL)SULFONYL]IMINO]PYRIMIDIN 1(2H) YL]ACETAMIDE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; MALE; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG EVALUATION, PRECLINICAL; EDEMA; FEMALE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MOLECULAR STRUCTURE; PAIN; PYRIMIDINES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 57349197388     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200800107     Document Type: Article

References (21)

1. S. M. Shondhi, N. Singhal, M. Johar, N. Reddy, J. W. Lown, Curr. Med. Chem. 2002, 9, 1045-1074.
2. N. H. Ouf, A. E.-G. E. Amr, A. A. Fayed, Monatsh. Chem. 2008, 139, 281-287.
3. S. M. Sondhi, J. Shubhi, A. D. Dwivedi, R. Shukla, R. Raghubir, Indian J. Chem. section b - organic chemistry including medicinal chemistry, 2008, 47, 136-143.
4. D. Ramesh, C. Chandrashekhar, V. P. Vaidya, Indian J. Heterocyclic Chem. 2006, 15, 319-322.
5. B. C. Bookser, B. G. Ugarkar, M. C. Matelich, R. H. Lemus, et al., J. Med. Chem. 2005, 48, 7808-7820.
6. O. Bruno, C. Brullo, S. Schenone, F. Bondavalli, et al., Bioorg. Med. Chem. 2004, 12, 553-561.
7. V. Jakubkiene, M. M. Burbulienè, G. Mekuskinè, E. Udrenaitè, et al., Il Farmaco 2003, 58, 323-328.
8. O. Bruno, S. Schenone, A. Ranise, E. Barocelli, et al., Arzneim. Forsch. (Drug Res.) 2000, 50, 140-147.
9. B. Tozkoparan, M. Ertan, B. Krebs, M. Läge, et al., Arch. Pharm. Pharm. Med. Chem. 1998, 331, 201-206.
10. A. Vidal, M. L. Ferrándiz, A. Ubeda, A. Acero-Alarcón, et al., Inflamm. Res. 2001, 50, 317-320.
11. A. Vidal, M. L. Ferrándiz, A. Ubeda, A. Acero-Alarcón, et al., J. Pharm. Pharmacol. 2001, 53, 1379-1385.
12. P. Fernández-Ferri, A. Ubeda, I. Guillén, J. Lasri, et al., Eur. J. Med. Chem. 2003, 38, 289-296.
13. A. Acero-Alarcón, T. Armero-Alarte, J. M. Jordá-Gregori, C. Rojas-Argudo, et al., Synthesis 1999, 12, 2124-2130.
14. K. Undheim, T. Benneche in Comprehensive Heterocyclic Chemistry (Eds.: A. R. Katrizky, C. W. Rees), Pergamon Press, Oxford, 1996, chapter 6.02, pp. 114 and references therein.
15. C. Hamdouchi, J. Blas, M. Prado, J. Gruber, et al., J. Med. Chem. 1999, 42, 50-59.
16. R. Koster, N. Anderson, E. J. De Beer, Fed. Proc. 1959, 18, 412-414.
17. N. B. Eddy, D. Leimbach, J. Pharmacol. Exp. Ther. 1953, 107, 385-393.
18. C. A Winter, E. A. Risley, G. W. Nuss, Proc. Soc. Exp. Biol. Med. 1962, 111, 544-547.
19. Iodoacetamides 5d-f were obtained according to the procedure described in the literature: C. Elorriaga, E. Fernández- Alvarez, F. González Muñoz, C. Montuenga, O. Nieto López, An. Quím. 1976, 72, 1018-1025.
20. J. S. Adams, G. F. Deebel, J. Chem. Eng. Data 1967, 12, 619-621.
21. Beilstein Handbuch der Organischen CHEMIE, Verlag Julius Springer, Berlin 1929, 12, 237.